BMQ Scale | Na | Mean (SD) | ||||
---|---|---|---|---|---|---|
Child | Young Adult | Adult | Parent of Child | |||
Age 10–17 N=49 | Age 18–24 N=75 | Age 25+ N=156 | Age 5–16 N=104 | |||
Specific Necessity–DFOb | 132 | 21.0 (3.3) | 20.5 (3.4) | 21.6 (3.7) | 21.3 (3.1) | |
Specific Concerns–DFOc | 131 | 14.4 (5.0) | 12.1 (4.2) | 12.9 (3.5) | 16.7 (2.8) | |
Specific Necessity-Oral Chelatorb | 256 | 19.0 (3.9) | 20.2 (3.9) | 20.9 (3.8) | 21.4 (3.4) | |
Specific Concerns-Oral Chelatorc | 256 | 10.8 (3.6) | 11.8 (3.9) | 12.2 (3.6) | 13.0 (4.0) | |
General Overused | 375 | 11.6 (2.5) | 11.8 (2.8) | 11.8 (2.8) | 12.2 (2.9) | |
General Harme | 380 | 9.5 (2.4) | 9.3 (2.7) | 8.9 (2.8) | 9.6 (3.2) | |
General Benefitf | 378 | 15.6 (2.3) | 15.7 (2.1) | 15.9 (2.4) | 16.3 (2.2) | |
Sensitive Somag | 379 | 11.3 (3.9) | 11.4 (3.8) | 12.0 (3.9) | 11.7 (3.7) | |
Comparison of DFO vs. Oral Chelation across age groups | ||||||
BMQ Scale | Specific Necessity | Specific Concerns | General Overuse | General Harm | General Benefit | Sensitive Soma |
p-valueh | 0.30 | <0.001 | 0.08 | 0.20 | 0.08 | <0.001 |